Nuwellis, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Nuwellis, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Shareholder Slice Ratio: Share count rose 481,670% in 3 years, so each share's slice of the company became smaller. Bigger rise in share count than almost all Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-96.3×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 81% of Healthcare companies in United States.
Cash Locked Ratio
$14For every $100 of sales, $14 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $21 tied up three years earlier.
Less money tied up than 70% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -3% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-3% / -75%In 3 years sales changed by -3% while total assets changed by -75%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
-41.4×Operating cash was negative last year, while some debt falls due within a year.
Lower than 69% of Healthcare companies in United States.
Cash Cushion Ratio
+43%Cash, after subtracting all debt, equals 43% of its market value (net cash).
Higher than 75% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
Nuwellis, Inc. owes $1.22 for every $1 it owns. Nuwellis, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
0.0Investors pay $0.0 for every $1 of Nuwellis, Inc.'s yearly profit, lower than almost all Healthcare companies in United States.
P/B ratio
-0.87Nuwellis, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$2 MThe total market value of all of Nuwellis, Inc.'s shares at today's price (share price × number of shares), smaller than almost all Healthcare companies in United States. PosiCap size class: Nano Cap.
Net worth (book value)
NegativeNuwellis, Inc.'s net worth is negative ($2 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
1.22×Nuwellis, Inc. owes $1.22 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.
Dividend yield
NoneNuwellis, Inc. does not currently pay a dividend.
Revenue growth
-5%Revenue fell 5% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Profit growth
LossNuwellis, Inc. made a loss in each of the last two years.
Profit margin
-211.9%Nuwellis, Inc. lost $212 for every $100 of revenue.
Interest cover
Not coveredNuwellis, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashNuwellis, Inc. held $1 M more cash than debt (net cash) at Dec 2025.
Questions
What is Nuwellis, Inc.'s P/E ratio?
Investors pay $0.0 for every $1 of Nuwellis, Inc.'s yearly profit, lower than almost all Healthcare companies in United States.
How much does Nuwellis, Inc. owe compared with what it owns?
Nuwellis, Inc. owes $1.22 for every $1 it owns, so it owes more than it owns, higher than 92% of Healthcare companies in United States.
Does Nuwellis, Inc. pay a dividend?
No. Nuwellis, Inc. does not currently pay a dividend.
Is Nuwellis, Inc.'s revenue growing?
Revenue fell 5% in the year to Dec 2025, and shrank 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.